Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nexalin Technology, Inc.

1.86
+0.921898.25%
Post-market: 1.64-0.2200-11.83%19:59 EDT
Volume:196.72M
Turnover:333.27M
Market Cap:32.82M
PE:-2.68
High:2.00
Open:1.83
Low:1.46
Close:0.9382
52wk High:4.49
52wk Low:0.5910
Shares:17.65M
Float Shares:14.90M
Volume Ratio:1,502.56
T/O Rate:1320.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6944
EPS(LYR):-0.8255
ROE:-242.01%
ROA:-138.67%
PB:5.50
PE(LYR):-2.25

Loading ...

Company Profile

Company Name:
Nexalin Technology, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
1776 Yorktown,Suite 550,Houston,Texas,United States
Zip Code:
77056
Fax:
- -
Introduction:
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.

Directors

Name
Position
Leslie Bernhard
Chairman of the Board
Mark White
President, Chief Executive Officer and Director
David Owens
Chief Medical Officer and Director
Alan Kazden
Director
Ben Hu
Director

Shareholders

Name
Position
Mark White
President, Chief Executive Officer and Director
Justin Van Fleet
Chief Financial Officer
Carolyn Shelton
Senior Vice-President of Quality, Regulatory and Clinical Affairs
David Owens
Chief Medical Officer and Director